Chandrakala Aluganti Narasimhulu
Overview
Explore the profile of Chandrakala Aluganti Narasimhulu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
420
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Imaralu O, Aluganti Narasimhulu C, Singal P, Singla D
Can J Physiol Pharmacol
. 2023 Sep;
102(1):14-25.
PMID: 37748207
Cardiovascular disease (CVD) complications have remained a major cause of death among patients with diabetes. Hence, there is a need for effective therapeutics against diabetes-induced CVD complications. Since its discovery,...
2.
Banerjee A, Aluganti Narasimhulu C, Singla D
Am J Physiol Heart Circ Physiol
. 2023 Aug;
325(4):H751-H767.
PMID: 37594487
The use of immunotherapies like pembrolizumab (PEM) is increasingly common for the management of numerous cancer types. The use of PEM to bolster T-cell response against tumor growth is well...
3.
Aluganti Narasimhulu C, Singla D
Antioxidants (Basel)
. 2023 Feb;
12(2).
PMID: 36829889
Diabetic myopathy involves hyperglycemia, oxidative stress, and inflammation. However, the role of hypercholesterolemia-induced inflammation-mediated pathological mechanisms leading to fibrosis, sarcopenia, deterioration of muscle, and muscle dysfunction in diabetes is not...
4.
Singla D, Cimen F, Aluganti Narasimhulu C
Mol Cell Biochem
. 2022 Nov;
478(7):1439-1445.
PMID: 36350463
Advancements in artificial intelligence (AI) strengthens life-altering technology that can not only reduce human workload but also enhance speed and efficiency in medicine. Medical image segmentation, for example, MRI analysis,...
5.
Aluganti Narasimhulu C, Singla D
Am J Physiol Heart Circ Physiol
. 2022 Jul;
323(3):H403-H420.
PMID: 35776683
Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, is a global pandemic impacting 254 million people in 190 countries. Comorbidities, particularly cardiovascular disease,...
6.
Aluganti Narasimhulu C, Parthasarathy S
Methods Mol Biol
. 2022 Mar;
2419:213-246.
PMID: 35237967
The concept of lipid peroxidation has been known for a long time. It is now well established that LDL plays a major role in atherosclerosis. Oxidized low-density lipoprotein (Ox-LDL) has...
7.
Mehu M, Aluganti Narasimhulu C, Singla D
Antioxidants (Basel)
. 2022 Feb;
11(2).
PMID: 35204116
Atherosclerosis is a chronic progressive disease that involves damage to the intima, inflammatory cell recruitment and the accumulation of lipids followed by calcification and plaque rupture. Inflammation is considered a...
8.
Aluganti Narasimhulu C, Singla D
Can J Physiol Pharmacol
. 2021 Dec;
100(5):441-452.
PMID: 34932406
Diabetic cancer patients were treated with doxorubicin (DOX), a potent chemotherapeutic drug that induces cardiac toxicity; however, molecular mechanisms of cardiac toxicity in this specific disease progression in patients and...
9.
Jiang X, Deme P, Gupta R, Litvinov D, Burge K, Parthasarathy S, et al.
Antioxidants (Basel)
. 2021 Aug;
10(8).
PMID: 34439506
Both pro- and antiatherosclerotic effects have been ascribed to dietary peroxidized lipids. Confusion on the role of peroxidized lipids in atherosclerotic cardiovascular disease is punctuated by a lack of understanding...
10.
Faizo N, Aluganti Narasimhulu C, Forsman A, Yooseph S, Parthasarathy S
Foods
. 2021 Feb;
10(2).
PMID: 33546321
Lipid peroxides (LOOHs) abound in processed food and have been implicated in the pathology of diverse diseases including gut, cardiovascular, and cancer diseases. Recently, RNA Sequencing (RNA-seq) has been widely...